PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,784.00
Bid: 2,780.00
Ask: 2,782.00
Change: -14.00 (-0.50%)
Spread: 2.00 (0.072%)
Open: 2,788.00
High: 2,794.00
Low: 2,770.00
Prev. Close: 2,798.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Debt

21 Sep 2022 17:07

RNS Number : 2076A
Coca-Cola HBC AG
21 September 2022
 

Coca-Cola HBC Finance B.V.

(the "Issuer")

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(the "Guarantor")

(a company incorporated with limited liability in Switzerland)

Zug, Switzerland and Amsterdam, The Netherlands - 21 September 2022 - The following Final Terms are available for viewing:

· Final Terms dated 21 September 2022 in respect of the €500 million aggregate principal amount of 2.750 per cent. Notes due 23 September 2025 (the "Final Terms");

to be issued by Coca-Cola HBC Finance B.V. under its €5 billion Euro Medium Term Note Programme, and guaranteed by Coca-Cola HBC AG.

This announcement must be read in conjunction with the Base Prospectus dated 6 September 2022 (the "Base Prospectus") which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018.

To view the Final Terms and the Base Prospectus, please paste the following URL into the address bar of your browser: https://www.coca-colahellenic.com/en/investor-relations/debt-investors.

The Final Terms have also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Coca-Cola HBC intends that an amount equal to the net proceeds of the Notes will be used to finance or refinance, in whole or in part, Eligible Green Projects that meet the eligibility criteria outlined in the Green Finance Framework available on Coca-Cola HBC's website at:

https://www.coca-colahellenic.com/en/investor-relations/debt-investors.

 

Disclaimer

The Base Prospectus and/or the Final Terms do not constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

 

Please note that the information contained in the Final Terms and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and/or the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and/or the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Head of Investor Relations

 

Tel: +44 7802 427505

 joanna.kennedy@cchellenic.com

Jemima Benstead

Investor Relations Manager

 

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

 

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Media:

Sonia Bastian

Head of Communications

 

 

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODEAKNFAESAEFA
Date   Source Headline
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCovid-19 update and actions
19th Mar 20203:39 pmRNSDirector/PDMR Shareholding
19th Mar 20203:01 pmRNSDirector/PDMR Shareholding
19th Mar 202011:16 amRNSWhat it takes to deliver 24/7
18th Mar 20201:36 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:39 pmRNSissue of equity and total voting rights
20th Feb 202012:25 pmRNSDirector/PDMR Shareholding
19th Feb 20203:04 pmRNSDirector/PDMR Shareholding
18th Feb 20202:17 pmRNSDirector/PDMR Shareholding
13th Feb 20207:00 amRNSQ4 ACCELERATION AND ANOTHER STRONG YEAR
7th Feb 20204:03 pmRNSNotice of Results - New time for the analysts call
3rd Feb 20209:21 amRNSIssue of equity and total voting rights
20th Jan 20203:27 pmRNSDirector/PDMR Shareholding
17th Jan 20209:26 amRNSNotice of Results
8th Jan 20202:01 pmRNSAthens Exchange trading date of ordinary shares
18th Dec 20192:00 pmRNSDirector/PDMR Shareholding
13th Dec 20191:50 pmRNSJoint Venture
6th Dec 20196:14 pmRNSCompletion of the acquisition of Lurisia
19th Nov 20193:31 pmRNSIssue of Debt
19th Nov 20192:10 pmRNSDirector/PDMR Shareholding
14th Nov 20195:49 pmRNSIssue of Debt
14th Nov 20198:44 amRNSIssue of Debt
13th Nov 20191:11 pmRNSPublication of Suppl.Prospcts
13th Nov 20197:00 amRNSSOLID QUARTER DESPITE ADVERSE WEATHER CONDITIONS
1st Nov 20199:41 amRNSBlock listing Interim Review
18th Oct 201912:55 pmRNSDirector/PDMR Shareholding
14th Oct 20191:03 pmRNSNotice of Results
8th Oct 20192:36 pmRNSPublication of Suppl.Prospcts
1st Oct 201910:53 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.